The Influence of Baseline Parameters on Changes in International Prostate Symptom Score with Dutasteride, Tamsulosin, and Combination Therapy among Men with Symptomatic Benign Prostatic Hyperplasia and an Enlarged Prostate: 2-Year Data from the CombAT Study-Reference-Cited by-同舟云学术

The Influence of Baseline Parameters on Changes in International Prostate Symptom Score with Dutasteride, Tamsulosin, and Combination Therapy among Men with Symptomatic Benign Prostatic Hyperplasia and an Enlarged Prostate: 2-Year Data from the CombAT Study

Published:2009-02 Issue:2 Volume:55 Page:461-471
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Roehrborn Claus G.,Siami Paul,Barkin Jack,Damião Ronaldo,Becher Edgardo,Miñana Bernardino,Mirone Vicenzo,Castro Ramiro,Wilson Timothy,Montorsi Francesco

Publisher

Elsevier BV

Subject

Urology

Reference14 articles.

1. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines);Madersbacher;Eur Urol,2004

2. American Urological Association Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations. J Urol 2003;170:530–47.

3. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25ml or greater;Kaplan;J Urol,2006

4. Combination therapy with dutasteride and tamsulosin in men with moderate-to-severe benign prostatic hyperplasia and prostate enlargement: the CombAT (Combination of Avodart and Tamsulosin) trial rationale and study design;Siami;Contemp Clin Trials,2007

5. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study;Roehrborn;J Urol,2008

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future aspects of plant derived bioactive metabolites as therapeutics to combat benign prostatic hyperplasia;Journal of Ethnopharmacology;2024-08

2. Exploring pharmacological interventions in benign prostate hyperplasia: the role of cost-effectiveness analysis in daily practice and future directions;Expert Opinion on Pharmacotherapy;2024-05-02

3. Impact of medical treatment on storage and voiding LUTS, nocturia, and quality of life in men at risk for progression;Prostate Cancer and Prostatic Diseases;2023-12-01

4. Global Incidence and Risk Factors Associated With Postoperative Urinary Retention Following Elective Inguinal Hernia Repair;JAMA Surgery;2023-08-01

5. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14